Opportunity ID: 220013

General Information

Document Type:: Grants Notice
Funding Opportunity Number:: RFA-HD-14-027
Funding Opportunity Title:: Safety and Effectiveness of Triple Antiretroviral Drug Strategies for Prevention of Mother to Child HIV Transmission (R01)
Opportunity Category:: Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity:: Health
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s):: 93.865 — Child Health and Human Development Extramural Research
Cost Sharing or Matching Requirement:: No
Version:: Synopsis 1
Posted Date:: Feb 11, 2013
Last Updated Date::
Original Closing Date for Applications:: Aug 30, 2013
Current Closing Date for Applications:: Aug 30, 2013
Archive Date:: Sep 30, 2013
Estimated Total Program Funding:: $ 5,000,000
Award Ceiling:: $
Award Floor:: $

Eligibility

Eligible Applicants:: Special district governments
Additional Information on Eligibility:: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name:: National Institutes of Health
Description:: This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH) invites applications to evaluate the safety and effectiveness of implementation of triple antiretroviral drug strategies for prevention of mother to child HIV transmission in resource-constrained settings – either an approach in which antiretroviral drugs stop after breastfeeding cessation in women who don’t require therapy for their own health (termed by the World Health Organization “Option B’) or a strategy in which life-long antiretroviral therapy is started in all pregnant women regardless of immune or clinical status (sometimes referred to as “Option B+”).
Link to Additional Information::
Grantor Contact Information:: If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version Modification Description Updated Date
Synopsis 1

Package Status

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Assistance Listings: 93.865
Competition ID: ADOBE-FORMS-B2
Competition Title: Adobe-Forms-B2
Opportunity Package ID: PKG00164150
Opening Date: Jul 30, 2013
Closing Date: Aug 30, 2013
Agency Contact Information:: eRA Commons Help Desk
Who Can Apply:: Organization Applicants
mendatory_forms SF424 (R & R) [V1.2]
Project/Performance Site Location(s) [V1.4]
Research And Related Other Project Information [V1.3]
Research And Related Senior/Key Person Profile (Expanded) [V1.2]
PHS 398 Cover Page Supplement [V1.4]
PHS 398 Research Plan [V1.3]
PHS 398 Checklist [V1.3]
optional_forms R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V1.2]
PHS 398 Modular Budget [V1.2]
Research & Related Budget [V1.1]
PHS Cover Letter [V1.2]

Packages

Assistance Listings Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions Who Can Apply:
93.865 ADOBE-FORMS-B2 Adobe-Forms-B2 PKG00164150 Jul 30, 2013 Aug 30, 2013 View eRA Commons Help Desk Organization Applicants